Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

Click for more information

0.00%

20.5¢ raptor resources limited

Just curious MB what proportion of your prophecies have...

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 3207 Last

Share
Profile

Follow
w_i_z_z_a

809 Posts.

156

09/07/20

13:43

Post #: 45751670
Share

Originally posted by MyBentley: ↑

This post is the opinion of the author...

This is fun..
Charts are created on pathways determined on what is...

RAP is going where no other Bio Tech company has gone before.
World communication via the internet will deliver virtual medical and health care to everyone on the planet no matter where they are on the planet.
This will be accomplished by 2022 by SPACEX. I see SPACEX as RAP's best business ever.

This is what I see will unfold within the next 6 months..
The CV has not gone away.
RAP will be hiring more expert software Sheldons to speed up the capacity for Resapp dx use globally on every telehealth platforms virtual respiratory clinics.

Government clinic doctors experience Resapp as a valued diagnostic tool in assisting in the clinical opinion of the doctor. Especially its value in Government and private Respiratory clinics that all consultations and use of Resapp dx is paid for.
This is social distance policy 101
Keep all respiratory patients at home and seen on line.
Resapp dx makes this clinically possile
In a Virtual Respiratory Clinic Resapp dx will be used in every consultation

Resapp dx is a world first and will be in use on every telehealth platform it is approved to be used.
Potentially right now the potential global use of Resapp dx in approved counties, being used as a triage tool in Virtual Respiratory clinics is 100, 000 uses a day at $5.00 a use.
$500,000 a day=$2.5 million a week=$10 million a month x 3 for a quarter =$30million X 4= $120million revenue for the year.

If I was conducting a telehealth respiratory clinic consultation I would have in front of me the patients name age and Resapp dx diagnosis

Before seeing the patient, I will have in front of me,
The Resapp dx diagnosis.

The patients current observations of triage nurse

the age of the client acute symptoms, acute history and

The patients history already gathered in triage

Current income from Resapp dx being $1o million a day
The big RAP picture is still right here in front of me...
I own a part of RAP and RAP is my business.

I see an introduction period of 3 months into the digital world of Doctors and teleheath Allied and mental health GP referrals for clients to have a respiratory consultation will expand potentially.

I see Doctor satisfaction with Resapp dx of delivering accurate satisfying virtual respiratory consultations for pathways of care increasing globally in the next 3 months.Resapp dx is approved for use and is available right now for all virtual respiratory clinics in 22 Countries.

I see Corviu and Phenix having a new web page "For all Respiratory related consultations CLICK HERE"
This is happening now....the government clinics are the pathway to medicare cover on Resapp test. The Governments pay $10 per Resapp test...The business referring use of Resapp $5.00 RAP $5.00

Because of CV...
Keep population at home when determining care pathways for respiratory care and possible containment.
I see an exponential growth of global telehealth platforms creating virtual "Respiratory Clinics" within 6 months
I see Resap dx in use globally in all these virtual "Respiratory Clinics" intake triage first contact nurse conducting the Resapp diagnostic test..

I see all Resaap dx tests used in Respiratory Clinics paid for by all governments medicare.
I feel the use of Resapp in Government CV clinics is to give doctors confidence in the clinical accuracy of Resapp dx and it ability to prioritize and recommend care pathways.

I see the first thing that will happen when the Respiratory clinic consults is a triage nurse face to face and explains to the patient how to and then complete a Resapp test.

The result of that Resapp test will prioritize and produce within 3 minutes if required a virtual face to face consultation with a doctor. The doctor will have in front of him the patient and the Resapp diagnosis.
The doctor can then observe and consult the patient on current symptoms and history.

Here is the global choice for doctors right now setting up and participating in existing telehealth platforms globally in 22 CE approved countries now...

CV is creating demand for virtual Respiratory Clinics globally....
To contain all respiratory face to face consultations away from doctors and health care workers.
The virtual Respiratory Clinic, reducing the number of face to face respiratory consultations is a current priority of governments globally.

Consulting a urgent virtual respiratory presentation of a patient the doctor has no stethoscope to help make a subjective guess better...

or

The doctor consulting in a virtual Respiratory Clinic has a Government approved Resapp dxEU respiratory diagnosis and the patient face to face.

Globally...

Happy Bentley

Expand

Just curious MB what proportion of your prophecies have materialised? Sounds like dribble as my complaining does these days!

Sentiment: holding because the product works but not happy with management Jan.

RAP Price at posting: 13.5¢ Sentiment: Hold Disclosure: Held
9 Upvote

1 Great analysis

Reply

Top Stories

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

What's causing the cost-of-living crisis, and how to navigate it

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

There are more pages in this discussion • 1,435 more messages in this thread...

First 3207 Last

Add RAP (ASX) to my watchlist